News
Atopy-on-a-chip model identifies effective active ingredient
Friday, 27 February 2026 12:37Using a two-organ disease model on a microchip, a German-Canadian research team involving research institutions from Vancouver, Berlin, and Münster has characterized the suitability of a low-molecular TSLP inhibitor to treat atopic diseases.
3Rs Award 2026 Mainz: Animal welfare prize also available for rehoming of lab animals
Monday, 23 February 2026 12:04For years, Mainz University Medical Center has been committed to promoting animal-free methods and only allowing research that complies with animal welfare standards. For this reason, an annual young scientist award for animal welfare in the field of 3R has been established in 2021. The application deadline for this year is March 23, 2026.
Epilepsy: using NAMs to develop better therapies for drug-resistant seizures
Friday, 20 February 2026 15:22A recent feature in the journal Drug Discovery Today discussed new animal-free approaches (NAMs) to research treatment options for drug-resistant epileptic seizures.
Japan: Medical products based on stem cells for patients
Friday, 20 February 2026 13:27A panel of experts from the Japanese Ministry of Health has approved two products made from iPS cells under certain conditions, paving the way for the world's first practical application of products made from iPS cells. The responsible ministry still has to authorize the process.
Ing4Life: Living nerve cells under natural conditions in real time
Wednesday, 18 February 2026 10:30At the Braunschweig Center for Systems Biology (BRICS), novel mini-laboratories are being developed on a chip that combine electrical, optical, and microfluidic technologies. This allows researchers to observe, stimulate, and analyze nerve cells under realistic conditions without animal testing.
Australia: The human heart may be able to partially recover after a myocardial infarction
Tuesday, 17 February 2026 13:59Researchers at the University of Sydney and other Australian institutions, led by Dr. Robert D. Hume, have discovered with the help of a donor heart that the heart cells of the human heart muscle can divide again to a certain extent after a myocardial infarction. This means that the human heart is capable of forming new muscle cells, even if only to a limited extent.
Model to study embryo Implantation
Sunday, 15 February 2026 10:50An international research team has developed an in vitro model that can replicate the human uterine lining (endometrium) with high biological accuracy. Using this system, the research team can «eavesdrop» on the communication between the embryo and the endometrium during the crucial developmental phase of embryo implantation.
Brussels: Industry Alliance for Microphysiological Systems (IAMPS) for constructive cooperation
Thursday, 12 February 2026 14:44The European industry leaders for microphysiological systems (MPS), AlveoliX (Switzerland), BiomimX (Italy), chiron (Netherlands), Dynamic42 (Germany), InSphero (Switzerland), MIMETAS (Netherlands), NETRI (France), React4Life (Italy), as well as TissUse (Germany) have announced the formation of the Industry Alliance for Microphysiological Systems (IAMPS). According to a press release, this is the world's first industry association dedicated to representing MPS providers.
Oregon: Primate research center to become sanctuary
Tuesday, 10 February 2026 14:21One of the largest monkey research centers in the United States has taken the first steps toward transforming itself into a primate sanctuary.
rFC assay: Selection of standard methods under consideration of sustainability criteria
Monday, 09 February 2026 21:07A research team at ACROBiosystems conducted a comprehensive comparability study between the LAL test and the company's proprietary rFC assay using several representative sample types. The results provide data and confirm a high degree of comparability between the two methods under realistic test conditions.
Dr. rer. nat.
Menschen für Tierrechte - Tierversuchsgegner Rheinland-Pfalz e.V.